Intra-articular corticosteroid knee injection induces a reduction in meniscal thickness with no treatment effect on cartilage volume: a case-control study.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 08 2020
Historique:
received: 21 11 2019
accepted: 02 07 2020
entrez: 16 8 2020
pubmed: 17 8 2020
medline: 29 12 2020
Statut: epublish

Résumé

Although intra-articular corticosteroid injections (IACI) are commonly used for the treatment of knee osteoarthritis (OA), there is controversy regarding possible deleterious effects on joint structure. In this line, this study investigates the effects of IACI on the evolution of knee OA structural changes and pain. Participants for this nested case-control study were from the Osteoarthritis Initiative. Knees of participants who had received an IACI and had magnetic resonance images (MRI) were named cases (n = 93), and each matched with one control (n = 93). Features assessed at the yearly visits and their changes within the follow-up period were from MRI (cartilage volume, meniscal thickness, bone marrow lesions, bone curvature, and synovial effusion size), X-ray (joint space width), and clinical (Western Ontario and McMaster Universities Osteoarthritis Index [WOMAC] pain score) data. Participants who received IACI experienced a transient and significantly greater rate of loss of the meniscal thickness (p = 0.006) and joint space width (p = 0.011) in the knee medial compartment in the year they received the injection, compared to controls. No significant effect of the IACI was found on the rate of cartilage loss nor on any other knee structural changes or WOMAC pain post-treatment. In conclusion, a single IACI in knee OA was shown to be safe with no negative impact on structural changes, but there was a transient meniscal thickness reduction, a phenomenon for which the clinical relevance is at present unknown.

Identifiants

pubmed: 32796866
doi: 10.1038/s41598-020-70064-4
pii: 10.1038/s41598-020-70064-4
pmc: PMC7427978
doi:

Substances chimiques

Adrenal Cortex Hormones 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13789

Références

Bruyere, O. et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin. Arthritis Rheum. https://doi.org/10.1016/j.semarthrit.2019.04.008 (2019).
doi: 10.1016/j.semarthrit.2019.04.008 pubmed: 31126594 pmcid: 6642878
Bruyere, O. et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis—from evidence-based medicine to the real-life setting. Semin. Arthritis Rheum. 45, S3-11. https://doi.org/10.1016/j.semarthrit.2015.11.010 (2016).
doi: 10.1016/j.semarthrit.2015.11.010 pubmed: 26806188
McAlindon, T. E. et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthr. Cartil. 22, 363–388. https://doi.org/10.1016/j.joca.2014.01.003 (2014).
doi: 10.1016/j.joca.2014.01.003 pubmed: 24462672
Hochberg, M. C. et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. (Hoboken) 64, 465–474 (2012).
doi: 10.1002/acr.21596
Jordan, K. M. et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann. Rheum. Dis. 62, 1145–1155 (2003).
doi: 10.1136/ard.2003.011742
Bhandari, M. et al. Intra-articular hyaluronic acid in the treatment of knee osteoarthritis: a Canadian evidence-based perspective. Ther. Adv. Musculoskel. Dis. 9, 231–246 (2017).
doi: 10.1177/1759720X17729641
Jevsevar, D. S. Treatment of osteoarthritis of the knee: evidence-based guideline, 2
doi: 10.5435/JAAOS-21-09-571 pubmed: 23996988
Bellamy, N. et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst. Rev. https://doi.org/10.1002/14651858.CD005328.pub2 (2006).
doi: 10.1002/14651858.CD005328.pub2 pubmed: 16625636
Bellamy, N. et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst. Rev. https://doi.org/10.1002/14651858.CD005321.pub2 (2006).
doi: 10.1002/14651858.CD005321.pub2 pubmed: 16625636
Paik, J., Duggan, S. T. & Keam, S. J. Triamcinolone acetonide extended-release: a review in osteoarthritis pain of the knee. Drugs 79, 455–462. https://doi.org/10.1007/s40265-019-01083-3 (2019).
doi: 10.1007/s40265-019-01083-3 pubmed: 30847805 pmcid: 6437125
Spitzer, A. I. et al. Safety and efficacy of repeat administration of triamcinolone acetonide extended-release in osteoarthritis of the knee: a phase 3b, open-label study. Rheumatol. Ther. 6, 109–124. https://doi.org/10.1007/s40744-019-0140-z (2019).
doi: 10.1007/s40744-019-0140-z pubmed: 30741382 pmcid: 6393263
Kompel, A. J. et al. Intra-articular corticosteroid injections in the hip and knee: perhaps not as safe as we thought? Radiology 293, 656–663. https://doi.org/10.1148/radiol.2019190341 (2019).
doi: 10.1148/radiol.2019190341 pubmed: 31617798
Raynauld, J. P. et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 48, 370–377. https://doi.org/10.1002/art.10777 (2003).
doi: 10.1002/art.10777 pubmed: 12571845
McAlindon, T. E. et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA 317, 1967–1975. https://doi.org/10.1001/jama.2017.5283 (2017).
doi: 10.1001/jama.2017.5283 pubmed: 28510679 pmcid: 5815012
Martel-Pelletier, J. et al. First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort. Ann. Rheum. Dis. 74, 547–556. https://doi.org/10.1136/annrheumdis-2013-203906 (2015).
doi: 10.1136/annrheumdis-2013-203906 pubmed: 24336337
Roubille, C. et al. Impact of disease treatments on the progression of knee osteoarthritis structural changes related to meniscal extrusion: data from the OAI progression cohort. Semin. Arthritis Rheum. 45, 257–267. https://doi.org/10.1016/j.semarthrit.2015.05.001 (2015).
doi: 10.1016/j.semarthrit.2015.05.001 pubmed: 26094904
Raynauld, J. P. et al. Long-term effects of glucosamine and chondroitin sulfate on the progression of structural changes in knee osteoarthritis: six-year followup data from the osteoarthritis initiative. Arthritis Care Res. (Hoboken) 68, 1560–1566. https://doi.org/10.1002/acr.22866 (2016).
doi: 10.1002/acr.22866
Raynauld, J. P. et al. Bone curvature changes can predict the impact of treatment on cartilage volume loss in knee osteoarthritis: data from a 2-year clinical trial. Rheumatology (Oxford) 56, 989–998. https://doi.org/10.1093/rheumatology/kew504 (2017).
doi: 10.1093/rheumatology/kew504
Dorais, M., Martel-Pelletier, J., Raynauld, J. P., Delorme, P. & Pelletier, J. P. Impact of oral osteoarthritis therapy usage among other risk factors on knee replacement: a nested case–control study using the Osteoarthritis Initiative cohort. Arthritis Res. Ther. 20, 172. https://doi.org/10.1186/s13075-018-1656-2 (2018).
doi: 10.1186/s13075-018-1656-2 pubmed: 30086786 pmcid: 6081796
Hafezi-Nejad, N. et al. Long term use of analgesics and risk of osteoarthritis progressions and knee replacement: propensity score matched cohort analysis of data from the Osteoarthritis Initiative. Osteoarthr. Cartil. 24, 597–604. https://doi.org/10.1016/j.joca.2015.11.003 (2016).
doi: 10.1016/j.joca.2015.11.003 pubmed: 26564576
Lapane, K. L. et al. Effects of prescription nonsteroidal antiinflammatory drugs on symptoms and disease progression among patients with knee osteoarthritis. Arthritis Rheumatol. 67, 724–732. https://doi.org/10.1002/art.38933 (2015).
doi: 10.1002/art.38933 pubmed: 25369996 pmcid: 4342290
Parsons, L. S. Performing a 1:N case-control match on propensity score. 2004. Proceedings of the Twenty-Ninth Annual SAS Users Group International Conference (SUGI 29). Montreal, Canada, Paper 165–129. https://support.sas.com/resources/papers/proceedings/proceedings/sugi129/165-129.pdf .
Dodin, P., Pelletier, J. P., Martel-Pelletier, J. & Abram, F. Automatic human knee cartilage segmentation from 3D magnetic resonance images. IEEE Trans. Biomed. Eng. 57, 2699–2711. https://doi.org/10.1109/TBME.2010.2058112 (2010).
doi: 10.1109/TBME.2010.2058112
Dodin, P., Abram, F., Pelletier, J.-P. & Martel-Pelletier, J. A fully automated system for quantification of knee bone marrow lesions using MRI and the osteoarthritis initiative cohort. J. Biomed. Graph Comput. 3, 51–65. https://doi.org/10.5430/jbgc.v3n1p51 (2013).
doi: 10.5430/jbgc.v3n1p51
Li, W. et al. Fully automated system for the quantification of human osteoarthritic knee joint effusion volume using magnetic resonance imaging. Arthritis Res. Ther. 12, R173. https://doi.org/10.1186/ar3133 (2010).
doi: 10.1186/ar3133 pubmed: 20846392 pmcid: 2991000
Berthiaume, M. J. et al. Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Ann. Rheum. Dis. 64, 556–563. https://doi.org/10.1136/ard.2004.023796 (2005).
doi: 10.1136/ard.2004.023796 pubmed: 15374855
Zeng, C. et al. Intra-articular corticosteroids and the risk of knee osteoarthritis progression: results from the Osteoarthritis Initiative. Osteoarthr. Cartil. 27, 855–862. https://doi.org/10.1016/j.joca.2019.01.007 (2019).
doi: 10.1016/j.joca.2019.01.007 pubmed: 30703543
McAlindon, T. E. & LaValley, M. P. Long-term intra-articular steroid injections and knee cartilage-reply. JAMA 318, 1185–1186. https://doi.org/10.1001/jama.2017.11339 (2017).
doi: 10.1001/jama.2017.11339 pubmed: 28973610
Eckstein, F. et al. Trajectory of cartilage loss within 4 years of knee replacement—a nested case–control study from the osteoarthritis initiative. Osteoarthr. Cartil. 22, 1542–1549. https://doi.org/10.1016/j.joca.2014.04.016 (2014).
doi: 10.1016/j.joca.2014.04.016 pubmed: 24792212 pmcid: 4184997
Eckstein, F. et al. Quantitative MRI measures of cartilage predict knee replacement: a case–control study from the Osteoarthritis Initiative. Ann. Rheum. Dis. 72, 707–714. https://doi.org/10.1136/annrheumdis-2011-201164 (2013).
doi: 10.1136/annrheumdis-2011-201164 pubmed: 22730370
Gale, D. R. et al. Meniscal subluxation: association with osteoarthritis and joint space narrowing. Osteoarthr. Cartil. 7, 526–532. https://doi.org/10.1053/joca.1999.0256  (1999).
doi: 10.1053/joca.1999.0256 pubmed: 10558850
Barnes, P. J. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br. J. Pharmacol. 148, 245–254. https://doi.org/10.1038/sj.bjp.0706736 (2006).
doi: 10.1038/sj.bjp.0706736 pubmed: 16604091 pmcid: 1751559
Riis, R. G. C. et al. The effects of intra-articular glucocorticoids and exercise on pain and synovitis assessed on static and dynamic magnetic resonance imaging in knee osteoarthritis: exploratory outcomes from a randomized controlled trial. Osteoarthr. Cartil. 25, 481–491. https://doi.org/10.1016/j.joca.2016.10.009 (2017).
doi: 10.1016/j.joca.2016.10.009 pubmed: 27746377
Henricsdotter, C. et al. Changes in ultrasound assessed markers of inflammation following intra-articular steroid injection combined with exercise in knee osteoarthritis: exploratory outcome from a randomized trial. Osteoarthr. Cartil. 24, 814–821. https://doi.org/10.1016/j.joca.2015.12.010 (2016).
doi: 10.1016/j.joca.2015.12.010 pubmed: 26746147

Auteurs

Jean-Pierre Pelletier (JP)

Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), 900 Saint-Denis, Suite R11.412A, Montreal, QC, H2X 0A9, Canada. dr@jppelletier.ca.

Jean-Pierre Raynauld (JP)

Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), 900 Saint-Denis, Suite R11.412A, Montreal, QC, H2X 0A9, Canada.

François Abram (F)

Medical Imaging Research and Development, ArthroLab Inc., Montreal, QC, H2K 1B6, Canada.

Marc Dorais (M)

StatSciences Inc., Notre-Dame-de-L'Île-Perrot, QC, J7V 0S2, Canada.

Patrice Paiement (P)

ArthroLab Inc., Montreal, QC, H2K 1B6, Canada.

Johanne Martel-Pelletier (J)

Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), 900 Saint-Denis, Suite R11.412A, Montreal, QC, H2X 0A9, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH